GlassScriptPhysician profile
Nicholas G Argerakis
NPI 1144582214
$13,296.67
in general payments reported to CMS, 2019-2025
29 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,512 · 2020: $1,483 · 2021: $1,062 · 2022: $1,828 · 2023: $2,864 · 2024: $1,922 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,925 · Travel and Lodging: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,925.24 |
| Travel and Lodging | $485.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,689.31 | 2021-2025 | Prostep Mica, Augment Injectable, Gravity |
| Royal Biologics, INC. | $2,537.90 | 2019-2023 | Fibrinet |
| Medtronic, INC. | $2,205.55 | 2022-2025 | Intellis Adaptivestim, Synchromedii |
| Medartis INC. | $1,438.60 | 2019 | |
| Orthofix Medical, INC. | $1,326.48 | 2020-2025 | Physio-Stim |
| Celularity INC. | $364.51 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $316.73 | 2023-2024 | Tapestry |
| Integra Lifesciences Corporation | $226.29 | 2020-2022 | |
| Amgen INC. | $219.60 | 2025 | Krystexxa |
| Arthrex, INC. | $204.95 | 2024 | |
| Horizon Therapeutics Plc | $203.17 | 2019-2022 | |
| Suvon Surgical LLC | $152.73 | 2024 | |
| Nevro Corp. | $150.00 | 2024 | Senza |
| Medline Industries LP | $147.89 | 2021 | |
| Next Science LLC | $140.43 | 2025 | Xperience, Blastx |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Solutions INC | $140.04 | 2023 | |
| Abbott Laboratories | $134.57 | 2025 | Esprit |
| Musculoskeletal Transplant Foundation INC. | $120.93 | 2019-2023 | |
| Smith+Nephew, INC. | $118.31 | 2019-2024 | Grafix Pl |
| Si-Bone, INC. | $94.96 | 2022 | |
| Novastep INC. | $87.46 | 2023 | Peca Bunion Correction System |
| Gramercy Extremity Orthopedics LLC | $81.31 | 2024 | |
| Seapearl East, INC | $55.85 | 2022 | |
| Fusion Orthopedics USA, LLC | $32.71 | 2024 | |
| Crossroads Extremity Systems, LLC | $32.05 | 2019 | |
| Maruho Medical, INC. | $24.80 | 2021 | |
| Tenex Health INC. | $16.89 | 2020 | |
| Wright Medical Technology, INC. | $16.68 | 2019 | |
| Melinta Therapeutics, LLC | $15.97 | 2023 | Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Argerakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.